Study Summary:
The primary objective is to investigate the efficacy, safety, and tolerability of a diabetes treatment compared to placebo as a therapy for patients with Type 2 Diabetes with insufficient glycemic control.
Qualified Participants Must:
• Be 18 years of age or older
•
Have type 2 diabetes
•
Have a BMI less than 45
Qualified Participants May Receive:
Study medication, physical exams and laboratories at no cost. You may receive compensation for time and travel.